跳至主要内容
临床试验/CTRI/2021/06/034308
CTRI/2021/06/034308招募中未知

urse led Genetic Counselling in Improving Awareness and Implementation of screening services for hereditary womens cancer NuGenA - NuGenA

Chittaranjan National Cancer Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • a) All non-mucinous epithelial ovarian cancer irrespective of their age
  • b) All first degree and second degree relatives of women diagnosed with
  • epithelial ovarian cancer and found to have deleterious mutation in BRCA1 or 2
  • c) If further funding is available: Then testing according to the NCCN guidelines
  • for Hereditary Breast and Ovarian cancer risk assessment
  • 1. Personal history of breast cancer and ââ?°Â¥1 of these:
  • ïâ??· Diagnosed at age ââ?°Â¤45 years
  • ïâ??· Diagnosed at age ââ?°Â¥50 years with ââ?°Â¥1 close blood relatives with breast cancer at
  • age 50 years and/or ââ?°Â¥1 close blood relatives with epithelial ovarian cancer at
  • ïâ??· 2 breast primaries when first breast cancer diagnosis occurred at age ââ?°Â¤50 years
  • ïâ??· Diagnosed at age ââ?°Â¤60 years with a triple negative breast cancer
  • ïâ??· Diagnosed at age ââ?°Â¤50 years with a limited family history
  • ïâ??· Diagnosed at any age with ââ?°Â¥2 close blood relatives with pancreatic cancer at
  • Close male blood relative with breast cancer
  • Individual of ethnicity associated with higher mutation frequency (e.g.,
  • Ashkenazi Jewish)
  • Personal history of epithelial ovarian cancer
  • ïâ??· Personal history of male breast cancer
  • Personal history of pancreatic cancer at any age with ââ?°Â¥2 close blood relatives
  • with breast and/or ovarian cancer and/or pancreatic cancer at any age
  • 2. No personal history of breast cancer, but ââ?°Â¥1 of these:
  • ïâ??· First- or second-degree blood relative meeting any of the above criteria
  • Third-degree blood relative with breast cancer and/or ovarian cancer with ââ?°Â¥2
  • close blood relatives with breast cancer (ââ?°Â¥1 with breast cancer at age ââ?°Â¤50
  • years) and/or ovarian cancer

排除标准

  • Any patient who does not meet the inclusion criteria

研究者

相似试验